Article Text

Download PDFPDF
BET 1: Oseltamivir use for quicker alleviation of symptoms, fewer hospital admissions and lower mortality in adult patients with influenza B
  1. Claire Bromley1,
  2. Charles Reynard2
  1. 1 Undergraduate Medical Student, University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK
  2. 2 University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK
  1. Correspondence to Claire Bromley; production.emj{at}bmjgroup.com

Abstract

A short cut review was carried out to establish whether Oseltamivir leads to faster alleviation of symptoms, fewer hospital admissions and lower mortality in adult patients with confirmed influenza B presenting to the Emergency Department. Two studies were directly relevant to the question using the described search methodology on Ovid Medline and Embase. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these papers are tabulated. The clinical bottom line: there is no good evidence that oseltamivir results in quicker alleviation of symptoms, fewer hospital admissions or lower mortality in adult patients with influenza B.

  • emergency care systems
View Full Text

Statistics from Altmetric.com

Footnotes

  • Patient consent for publication Not required.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.